These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8641218)

  • 21. 24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure.
    Gal-Moscovici A; Rubinger D; Popovtzer MM
    Clin Nephrol; 2000 May; 53(5):362-71. PubMed ID: 11305809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parathyroid hormone sensitizes long bones to the stimulation of bone resorption by 1,25-dihydroxyvitamin D3.
    van Leeuwen JP; Birkenhäger JC; Bos MP; van der Bemd GJ; Herrmann-Erlee MP; Pols HA
    J Bone Miner Res; 1992 Mar; 7(3):303-9. PubMed ID: 1585831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of vitamin D metabolites in the prevention of the osteopenia induced by ovariectomy in the axial and appendicular skeleton of the rat.
    Erben RG; Kohn B; Weiser H; Sinowatz F; Rambeck WA
    Z Ernahrungswiss; 1990 Dec; 29(4):229-48. PubMed ID: 2080635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6).
    Duque G; Macoritto M; Dion N; Ste-Marie LG; Kremer R
    Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E723-30. PubMed ID: 15572658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1 alpha,25-Dihydroxyvitamin D3[1 alpha,25-(OH)2D3]-26,23-lactone inhibits 1,25-(OH)2D3-mediated fusion of mouse bone marrow mononuclear cells.
    Ishizuka S; Kurihara N; Hakeda S; Maeda N; Ikeda K; Kumegawa M; Norman AW
    Endocrinology; 1988 Aug; 123(2):781-6. PubMed ID: 3396507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal response of osteoblasts from Hyp mice to 1,25-dihydroxyvitamin D3.
    Yamamoto T; Ecarot B; Glorieux FH
    Bone; 1992; 13(3):209-15. PubMed ID: 1322149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Action of 24R, 25 dihydroxyvitamin D3 (24,25 (OH)2D3) on bone in vivo.
    Nakamura T; Kurokawa T; Orimo H
    In Vivo; 1987; 1(5):313-7. PubMed ID: 2979799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of ornithine decarboxylase and creatine kinase in soft and hard tissue of vitamin D-deficient chicks following parenteral application of 1,25-dihydroxyvitamin D3 or 24R,25-dihydroxyvitamin D3.
    Ittel TH; Ross FP; Norman AW
    J Bone Miner Res; 1986 Feb; 1(1):23-31. PubMed ID: 3509739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
    Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteocalcin abnormalities in Hyp mice reflect altered genetic expression and are not due to altered clearance, affinity for mineral, or ambient phosphorus levels.
    Carpenter TO; Gundberg CM
    Endocrinology; 1996 Dec; 137(12):5213-9. PubMed ID: 8940337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous infusion of 1,25-dihydroxyvitamin D3 stimulates bone turnover in the normal young mouse.
    Marie PJ; Travers R
    Calcif Tissue Int; 1983 Jul; 35(4-5):418-25. PubMed ID: 6688545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma 24,25-dihydroxyvitamin D3 concentrations in X-linked hypophosphatemic mice: studies using mass fragmentographic and radioreceptor assays.
    Cunningham J; Coldwell RD; Jones G; Tenenhouse HS; Trafford DJ; Makin HL
    J Bone Miner Res; 1990 Feb; 5(2):173-7. PubMed ID: 2316405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by aminohydroxypropylidene bisphosphonate (AHPrBP) of 1,25(OH)2 vitamin D3-induced stimulated bone turnover in the mouse.
    Marie PJ; Hott M; Garba MT
    Calcif Tissue Int; 1985 May; 37(3):268-75. PubMed ID: 3926276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-related effects of 1,25-dihydroxyvitamin D3 on growth, modeling, and morphology of fetal mouse metatarsals cultured in serum-free medium.
    Bagi CM; Miller SC
    J Bone Miner Res; 1992 Jan; 7(1):29-40. PubMed ID: 1549956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healing of rachitic lesions in chicks by 24R,25-dihydroxycholecalciferol administered locally into bone.
    Lidor C; Atkin I; Ornoy A; Dekel S; Edelstein S
    J Bone Miner Res; 1987 Apr; 2(2):91-8. PubMed ID: 3502667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1,25 dihydroxyvitamin D3 alone or in combination with parathyroid hormone does not increase bone mass in young rats.
    Gunness-Hey M; Gera I; Fonseca J; Raisz LG; Hock JM
    Calcif Tissue Int; 1988 Nov; 43(5):284-8. PubMed ID: 3145794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the 1,25-(OH)2D3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells.
    Ishida H; Bellows CG; Aubin JE; Heersche JN
    Endocrinology; 1993 Jan; 132(1):61-6. PubMed ID: 8419147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential regulation of insulin-like growth factor-I (IGF-I) and IGF-II release from cultured neonatal mouse calvaria by parathyroid hormone, transforming growth factor-beta, and 1,25-dihydroxyvitamin D3.
    Linkhart TA; Keffer MJ
    Endocrinology; 1991 Mar; 128(3):1511-8. PubMed ID: 1999170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.